Tradestie Institutional Equity Comparison Engine

ABOS vs DOOO โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

DOOO Overall Edge

DOOO Captures Institutional Edge (3โ€“1 Pillars ยท 9โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to BRP Inc. Common Subordinate Voting Shares (DOOO) driven by superior Valuation, Growth & Margin, Momentum & Technical while ABOS counters with relative strength in Options & Structure. Fundamentally, ABOS trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus DOOO at 14.4x Forward P/E and 4.8% operating margin (+4.3% YoY). In options structure, ABOS sits in UNCLASSIFIED (41st %ile IV; Dealer Gamma Walls on Pro) against DOOO sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner DOOO
ABOS N/M vs DOOO 14.4x Fwd P/E
Growth & Margin Winner DOOO
Op Margin 0.0% vs 4.8% ยท YoY +0.0% vs +4.3%
Momentum & Technical Winner DOOO
1Y -88.0% vs +54.2% ยท 52W Pos 1% vs 96%
Options & Structure Winner ABOS
UNCLASSIFIED (41st %ile IV) vs UNCLASSIFIED (<1st %ile IV)
ABOS NASDAQ
Acumen Pharmaceuticals, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$0.19
-3.52% 1D
Market Cap $14.0M
1M Return -90.95%
1Y Return -87.97%
Forward P/E N/M
Unified AI Score
49.2 / 100 HOLD
Tech 45.0 Fund 58.0 Flow 68.0 Mom 55.0
DOOO NASDAQ
BRP Inc. Common Subordinate Voting Shares
Miscellaneous Transportation Equipment
$76.20
+1.55% 1D
Market Cap $5.1B
1M Return +20.36%
1Y Return +54.19%
Forward P/E 14.4x
Unified AI Score
64.6 / 100 BUY
Tech 60.0 Fund 54.0 Flow 50.0 Mom 47.6

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ABOS -87.97% DOOO +54.19% Spread: +2.83 pp (ABOS Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ABOS TTM Op. Margin: 0.0% DOOO TTM Op. Margin: 4.8%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ABOS vs DOOO. Trailing 12-month operating profitability (ABOS 0.0% vs DOOO 4.8%) and valuation multiples (ABOS N/M vs DOOO 14.4x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ABOS (1) vs DOOO (9)
Institutional Metric ABOS DOOO Criterion Row Winner
Market Capitalization Scale $14.0M $5.1B Larger Scale DOOO
Trailing P/E Ratio Valuation N/M 36.1x Lower Multiple DOOO
Forward P/E Ratio Valuation N/M 14.4x Lower Multiple DOOO
Revenue Growth (YoY) Growth +0.0% +4.3% Higher Growth DOOO
Operating Margin (TTM) Profitability 0.0% 4.8% Higher Margin DOOO
Net Profit Margin Profitability 0.0% -0.5% Higher Margin ABOS
Return on Equity (ROE) Capital Efficiency -162.7% 37.5% Higher ROE DOOO
52-Week Range Position Momentum 1% ($0โ€“$4) 96% ($32โ€“$78) Stronger Trend DOOO
Beta / 30D Volatility Risk Regime 2.62ฮฒ ยท 326% Vol 0.97ฮฒ ยท 39% Vol Lower Realized Risk DOOO
Unified Institutional Score Composite Signal 49.2 / 100 (HOLD) 64.6 / 100 (BUY) Higher Composite DOOO

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ABOS vs DOOO Buy Guide
ABOS UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 41st %ile
IV Regime Balanced (25thโ€“60th %ile)
Live ABOS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
DOOO UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live DOOO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ABOS nor DOOO registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.